Verdence Capital Advisors LLC lowered its stake in shares of Relx Plc (NYSE:RELX – Free Report) by 10.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 36,538 shares of the technology company’s stock after selling 4,182 shares during the period. Verdence Capital Advisors LLC’s holdings in Relx were worth $1,985,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Larson Financial Group LLC lifted its stake in Relx by 612.5% during the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock valued at $26,000 after acquiring an additional 441 shares during the period. WPG Advisers LLC bought a new position in Relx during the 1st quarter valued at about $28,000. Golden State Wealth Management LLC lifted its stake in Relx by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock valued at $30,000 after acquiring an additional 294 shares during the period. Cornerstone Planning Group LLC lifted its stake in Relx by 325.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock valued at $37,000 after acquiring an additional 530 shares during the period. Finally, Ameritas Advisory Services LLC bought a new position in Relx during the 2nd quarter valued at about $64,000. Institutional investors own 15.02% of the company’s stock.
Relx Trading Up 0.7%
Shares of RELX opened at $45.15 on Tuesday. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. Relx Plc has a 1 year low of $44.19 and a 1 year high of $56.33. The company has a 50 day simple moving average of $47.09 and a two-hundred day simple moving average of $50.78. The firm has a market cap of $82.51 billion, a P/E ratio of 24.27, a price-to-earnings-growth ratio of 2.92 and a beta of 0.87.
Relx Cuts Dividend
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on RELX shares. Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Barclays reiterated an “overweight” rating on shares of Relx in a research note on Tuesday, October 7th. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Relx in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy”.
View Our Latest Stock Report on Relx
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- What is the Hang Seng index?
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- How to Effectively Use the MarketBeat Ratings Screener
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What is a buyback in stocks? A comprehensive guide for investors
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.